Arrowhead Pharmaceuticals, Inc. (ARWR)

82.39 -2.52 (-2.97%) USD  |  NASDAQ  |  Aug 31, 16:00
82.20 -0.19 (-0.23%) After-Hours: 07:17
More

Arrowhead Pharmaceuticals Total Long Term Debt (Quarterly) : 1.371B for June 30, 2026

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 1.371B
March 31, 2026 1.366B
December 31, 2025 680.23M
September 30, 2025 726.39M
June 30, 2025 706.28M
March 31, 2025 733.73M
December 31, 2024 865.49M
September 30, 2024 845.57M
June 30, 2024 448.07M
March 31, 2024 394.57M
December 31, 2023 388.85M
September 30, 2023 372.93M
June 30, 2023 79.91M
March 31, 2023 80.07M
December 31, 2022 79.47M
September 30, 2022 78.80M
June 30, 2022 78.23M
March 31, 2022 22.70M
December 31, 2021 22.49M
September 30, 2021 23.30M
June 30, 2021 22.85M
March 31, 2021 22.53M
December 31, 2020 19.68M
September 30, 2020 20.04M
June 30, 2020 20.36M
Date Value
March 31, 2020 14.18M
December 31, 2019 14.38M
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 2.325M
June 30, 2018 2.378M
March 31, 2018 2.431M
December 31, 2017 2.483M
September 30, 2017 2.534M
June 30, 2017 2.583M
March 31, 2017 2.632M
December 31, 2016 2.680M
September 30, 2016 2.728M
June 30, 2016 3.323M
March 31, 2016 0.65M
December 31, 2015 0.7042M
September 30, 2015 0.7583M
June 30, 2015 0.8122M
March 31, 2015 0.8658M
December 31, 2014 0.9192M
September 30, 2014 1.022M
June 30, 2014 1.075M
March 31, 2014 2.128M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. 1.046B
Revolution Medicines, Inc. 1.174B
Moderna, Inc. 1.266B
Intellia Therapeutics, Inc. 50.07M
Denali Therapeutics, Inc. 27.60M